175 related articles for article (PubMed ID: 6767407)
21. Analysis of the antigenic relationship of various derivatives of n-acetyl-muramyl-l-ala-d-isoglutamine (MDP), using anti-MDP antibodies.
Bahr GM; Carelli C; Audibert F; Modabber F; Chedid L
Mol Immunol; 1982 May; 19(5):737-45. PubMed ID: 7110143
[TBL] [Abstract][Full Text] [Related]
22. [Pathology of epithelioid cell granulomas in relation to the cell components of Mycobacterium tuberculosis].
Morikawa K; Okuyama H; Okabe M; Yasumizu Y; Azuma I
Kekkaku; 1979 Oct; 54(10):504-6. PubMed ID: 119086
[No Abstract] [Full Text] [Related]
23. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs.
Woodard LF; Toone NM; Jasman RL
Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042
[TBL] [Abstract][Full Text] [Related]
24. [Epithelioid granuloma formation by a bacterial cell wall constituent. (Part 2)].
Tanaka A
Kekkaku; 1983 Jan; 58(1):39-51. PubMed ID: 6405070
[No Abstract] [Full Text] [Related]
25. Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate.
Yarkoni E; Lederer E; Rapp HJ
Infect Immun; 1981 Apr; 32(1):273-6. PubMed ID: 7216489
[TBL] [Abstract][Full Text] [Related]
26. Comparison of muramyl dipeptide, trehalose dimycolate, and dimethyl dioctadecyl ammonium bromide as adjuvants in Brucella abortus 45/20 vaccines.
Woodard LF; Toone NM; McLaughlin CA
Infect Immun; 1980 Nov; 30(2):409-12. PubMed ID: 6777304
[TBL] [Abstract][Full Text] [Related]
27. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
Souvannavong V; Adam A
Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
[TBL] [Abstract][Full Text] [Related]
28. Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.
Humphres RC; Henika PR; Ferraresi RW; Krahenbuhl JL
Infect Immun; 1980 Nov; 30(2):462-6. PubMed ID: 7439991
[TBL] [Abstract][Full Text] [Related]
29. Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.
Parant M; Parant F; Chedid L; Yapo A; Petit JF; Lederer E
Int J Immunopharmacol; 1979; 1(1):35-41. PubMed ID: 551094
[TBL] [Abstract][Full Text] [Related]
30. The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.
Dinarello CA; Elin RJ; Chedid L; Wolff SM
J Infect Dis; 1978 Dec; 138(6):760-7. PubMed ID: 368262
[TBL] [Abstract][Full Text] [Related]
31. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
[TBL] [Abstract][Full Text] [Related]
32. [Epithelioid granuloma formation by a bacterial cell wall constituent. (Part 1)].
Tanaka A
Kekkaku; 1982 Dec; 57(12):671-86. PubMed ID: 7182646
[No Abstract] [Full Text] [Related]
33. Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP).
Audibert F; Chedid L; Lefrancier P; Choay J; Lederer E
Ann Immunol (Paris); 1977; 128C(3):653-61. PubMed ID: 869513
[TBL] [Abstract][Full Text] [Related]
34. Arthritis-inducing ability of a synthetic adjuvant, N-acetylmuramyl peptides, and bacterial disaccharide peptides related to different oil vehicles and their composition.
Kohashi O; Tanaka A; Kotani S; Shiba T; Kusumoto S; Yokogawa K; Kawata S; Ozawa A
Infect Immun; 1980 Jul; 29(1):70-5. PubMed ID: 7399708
[TBL] [Abstract][Full Text] [Related]
35. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP).
Parant M; Riveau G; Chedid L
Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684
[TBL] [Abstract][Full Text] [Related]
36. [Biochemical and immunological properties of the fractions of tubercle bacilli].
Azuma I
Kekkaku; 1998 Feb; 73(2):65-70. PubMed ID: 9545698
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of the humoral and cellular immune response of guinea pigs after injection of the synthetic adjuvant N-acetylmuramyl L-alanyl-D-isoglutamine: comparison with Freund complete adjuvant.
Souvannavong V; Adam A; Lederer E
Infect Immun; 1978 Mar; 19(3):966-71. PubMed ID: 346491
[TBL] [Abstract][Full Text] [Related]
38. Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptides.
Bahr GM; Chedid LA; Behbehani K
Cell Immunol; 1987 Jul; 107(2):443-54. PubMed ID: 3496165
[TBL] [Abstract][Full Text] [Related]
39. Three-dimensional study of epithelioid cells by a quick-freezing and deep-etching method in muramyl dipeptide-induced granulomas.
Baba T; Sakaguchi N; Hotchi M; Ohno S
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 63(1):63-70. PubMed ID: 1362023
[TBL] [Abstract][Full Text] [Related]
40. Freund's adjuvant, NOD2 and mycobacteria.
Behr MA; Divangahi M
Curr Opin Microbiol; 2015 Feb; 23():126-32. PubMed ID: 25483349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
